News

An eye-opening Canadian study has surprising findings about the risk of death and antidepressants.

San Diego-area healthcare organizations experience promising results after using population health strategies to improve hypertension treatment across the region.

The access problems many rural health plan members face cannot be rectified overnight, but resources, creativity and time can bring these populations up to par with their more urban counterparts.

Avalere conducted an analysis to assess the effect of MIPS. Here are the surprising results.

Physicians need to be able to move quickly to care for patients with AML, and they need to have payers on board.

Learn from hospitals and managed care organizations at the forefront of successful initiatives. Read more.

How payers, providers are improving work flows, patient care, and cutting costs.

New healthcare terms and topics constantly crop up. Here are six to keep an eye on right now.

FDA approved a new treatment for certain breast cancer patients who are not responding to treatment.

Finding ways to communicate directly with and provide tailored services to LGBT individuals has been a challenge for managed care organizations, but experts say breaking barriers is imperative.

More support for clinical trials and a wider lens for rare diseases in children sets the category on fire.

New physician-administered therapies on the horizon may help rein in the opioid epidemic.

A new study reveals how participation in the Supplemental Nutritional Assistance Program could impact healthcare costs for low-income individuals.

Between 1990 and 2013, the maternal mortality ratio more than doubled in the United States. Find out what experts say can resolve the issue.

Now that the Graham-Cassidy bill has failed, here’s what healthcare executives should do to plan for 2018.

In the wake of the failure of the Graham-Cassidy bill, experts share what’s ahead for health policy.

A new study has shocking results about beta blocker use in heart-attack survivors.

A new HealthMine survey sheds light on how payers can better connect Medicare members to their health plan.

Pharma maker pleads guilty that one of its major drugs was misbranded in a federal court case brought by FDA and the US Department of Justice.

FDA approved the first generic version of oseltamivir phosphate (Tamiflu, Roche) for oral suspension to treat influenza A and B, plus 2 other noteworthy therapies.

FDA is advising that these 2 opioid addiction medications should not be withheld from patients taking benzodiazepines or other drugs that depress the central nervous system.

A survey from HealthScape Advisors and the Health Plan Alliance has revealing findings about value-based payment models.

Payers must reinvent efforts to reduce cancer cost and increase quality for a value-based care world. Here’s five rules to follow.

Here are the top 10 states with the highest uninsured rate, according to personal-finance website WalletHub.

A poll by Morning Consult on behalf of University of Phoenix, has revealing results about online health resources.

While FDA has approved a handful of biosimilar drugs, the agency just approved the first biosimilar that treats a variety of types of cancer.

A new poll has interesting findings related to patient preferences and needs. Read more.

Universal healthcare is top of mind for healthcare stakeholders. Here’s four things you need to know about it right now.